Banzel (Eisai Inc.)


Welcome to the PulseAid listing for the Banzel drug offered from Eisai Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eisai Inc.
NON-PROPRIETARY NAME: rufinamide
SUBSTANCE NAME: RUFINAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-11-14
END MARKETING DATE: 0000-00-00


Banzel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBanzel from Eisai Inc.
LABELER NAME: Eisai Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2008-11-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62856-582_1a1fe14e-2ba4-415e-b451-6493720f1cb3
PRODUCT NDC: 62856-582
APPLICATION NUMBER: NDA021911

Other RUFINAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eisai Inc.Banzel